Tenpoint gets FDA nod for presbyopia eye drop and $235Mnews2026-01-29T06:08:04+00:00January 29th, 2026|Endpoints News|
ChenMed CEO warns against GLP-1s for seniorsnews2026-01-28T23:12:32+00:00January 28th, 2026|Endpoints News|
Round three of IRA negotiations is expected to be ‘manageable’ for pharmanews2026-01-28T21:19:03+00:00January 28th, 2026|Endpoints News|
Oral Rogaine maker Veradermics looks to raise $181M from IPOnews2026-01-28T19:18:51+00:00January 28th, 2026|Endpoints News|
FDA asks court to pause Louisiana’s abortion pill fightnews2026-01-28T19:18:46+00:00January 28th, 2026|Endpoints News|
Lonza still intends to sell its capsules and health ingredients businessnews2026-01-28T18:51:06+00:00January 28th, 2026|Endpoints News|
Teva CEO says it has successfully transitioned into a biopharma companynews2026-01-28T17:18:00+00:00January 28th, 2026|Endpoints News|
FDA suspends two Regenxbio gene therapy trials after patient developed brain tumornews2026-01-28T15:56:29+00:00January 28th, 2026|Endpoints News|
HHS seeks to protect drugmakers from anti-kickback laws ahead of TrumpRx launchnews2026-01-28T15:26:09+00:00January 28th, 2026|Endpoints News|
Eikon seeks $273M IPO with pipeline led by Chinese cancer drugsnews2026-01-28T15:25:44+00:00January 28th, 2026|Endpoints News|
